10Sediman AD,Scher HI,Petrylak D,et al.Estamustine and vinblastine: use of prostate-specific antigen as a clinical trial end point for hormane refrectory prostatic cancer.J Urol,1992,147:931-934.
1Ae Ngibise K A, Masanja H, Kellerman R, et al. Risk factors for injury mortality in rural Tanzania: a secondarydata analysis [ J] B MJ Open, 2012,2 ( 6 ) : pii : eO01721.
2Rockett I R, Regier M D, Kapusta N D, et al. Leading causes of unintentional and intentional injury mortality : u- nited states, 2000-2009 [ J ]. Am J Public Health, 2012, 102( 11 ) : e84-e92.
3Minifio A M, Anderson R N, Fingerhut L A, et al. Deaths : injuries, 2002 [ J ]. Natl Vital Stat Rep, 2006,54 (10) :1-124.
4Kynast Wolf G, Preuss M, Sie A, et al. Seasonal pat- terns of cardiovascular disease mortality of adults in Burkina Faso, West Africa [ J ]. Trop Med Int Health, 2010,15(9) :1082-1089.
5Peden M, Scurfield R, Sleet D, et al. Word report on road traffic injury prevention[ M ]. Geneva: Word Health Organization, 2004:26-34.
6Mamady K, Yao H, Zhang X, et al. The injury mortality burden in Guinea[ J ]. BMC Public Health, 2012 ( 12 ) : 733.
